Dr Duan selected in "Double Hundred Plan"
In March 2013, Dr. Duan Xiaobo, director of research and development of Wiz Biotech, was selected as the fourth batch of high-level talents in Xiamen "Double Hundred Plan" A+ entrepreneurial and innovative talents.
Xiamen WIZ Biotech Co., LTD
Xiamen WIZ Biotech Co., LTD., founded in July 2013, is a high-tech company engaged in the research and development, production and sales of rapid diagnostic reagents and instruments for the purpose of "focusing on diagnostic technology and improving the quality of life". It is a state-level high-tech enterprise, a small giant enterprise of science and technology in Fujian Province, and a specialized and innovative small and medium-sized enterprise. New Third Board innovation layer enterprises (securities code: 839355). The company has been striving to become a leader in the field of POCT rapid diagnostic medicine. At present, the company has obtained more than 120 reagent menus at home and abroad, covering Malaria Test, Protein Urine Test, Hepatitis Test, Colon Cancer Test and other products. It has a platform for the development and preparation of antigen and antibody raw materials, as well as a mature immunochromatography technology platform, and focuses on the layout of microfluidic platform, molecular diagnosis platform, chemiluminescence and other platforms.
